- Study to Evaluate Model for Improving the Efficiency of the Breast Cancer Detection Process in the Clinical Practice Setting
- Relationship Embodies GE's Healthymagination Goal of Increasing Access to Better Healthcare at Lower Costs
LOS ANGELES, Sept. 18, 2012 (GLOBE NEWSWIRE) -- GE Healthcare (a business division of General Electric Company) today announced it is joining with RadNet (Nasdaq:RDNT), a network of outpatient diagnostic imaging centers, to pilot its Best Pathways initiative, a breast cancer detection optimization model. GE Healthcare and RadNet will evaluate the clinical breast cancer detection process to quantify inefficient diagnostic patterns and identify optimal paths to lower cost and improve patient outcomes. This program will focus on subpopulations of women in which guidelines are lacking and substantial variability is observed in clinical practice.
Best Pathways is designed to address a significant need for increased insight into the breast cancer detection process--from a patient's initial screening mammogram to final biopsy. Historically, diagnostic processes have been variable and inefficient, leading to frequent false-positive test results and costly follow-up imaging procedures. In 2009, the U.S. Preventative Services Task Force (USPSTF) tightened recommendations for breast cancer screenings across multiple patient populations, citing lack of evidence supporting benefits and high cost of the screenings as primary factors.
"This initiative will provide deeper understanding of care patterns and ways to optimize processes to ensure the best outcomes for patients and operational efficiency for providers," said Dr. Howard Berger, president and chief executive officer (CEO), RadNet. "With the technological and process expertise that GE Healthcare offers, as well as our shared passion for improving access to low-cost healthcare solutions, we look forward to improving care protocols in the detection of breast cancer."GE Healthcare and RadNet will identify and quantify diagnostic costs per cancer detected, the types of breast cancer detected and their stage distribution, the number of imaging tests and biopsies required to detect each cancer, and the incremental cost-effectiveness ratios for each diagnostic case. Diagnostic patterns will be identified based on patient population characteristics including age, risk of developing breast cancer and breast density. The program will also seek to define optimal diagnostic paths for patient care based on rigorous data and analysis.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV